Organon & Co. · NYSE:OGN
Weaver Kirke exercised options for 18,513 Organon & Co. shares (Form 4)
Traded Mar 31, 2026 · Filed Apr 2, 2026
On Mar 31, 2026, Weaver Kirke (Gen. Counsel & Corp. Secy.) exercised options for 18,513 Organon & Co. shares, leaving 92,639 shares. Filed Apr 2, 2026 (Form 4).
- Options exercised
- 18,513 shares
- Holding after
- 92,639 shares
- Trading plan
- No
- Role
- Gen. Counsel & Corp. Secy.
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Common Stock | Option exercise | 6,201 | 85,602 | Direct | |
| Mar 31, 2026 | Common Stock | Shares withheld for tax | 1,767 | US$5.70 | 83,835 | Direct |
| Mar 31, 2026 | Common Stock | Option exercise | 12,312 | 96,147 | Direct | |
| Mar 31, 2026 | Common Stock | Shares withheld for tax | 3,508 | US$5.70 | 92,639 | Direct |
Source
Related
- Organon & Co.
- Weaver Kirke
- Organon & Co. shareholders
- Schedule 13G · Pentwater Capital Management LP · Aug 14, 2026
- Form 4 · Arjona Ferreira Juan Camilo · Aug 12, 2026
- Form 4 · Drinane Juliana Papa · Aug 5, 2026
- Schedule 13G/A · Vanguard Portfolio Management LLC · Jul 31, 2026
- Form 4/A · Holzbaur Lynette · May 7, 2026